January 9, 2026 · Form 4 insider transaction
Lippis Daniel J. bought 1,019 shares of Edwards Lifesciences Corporation at $59.26 per share, a transaction worth $60.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025.